Lineage Cell Therapeutics, Inc. (LCTX)
1.685
-0.06
(-3.71%)
USD |
NYAM |
Dec 19, 16:00
1.685
0.00 (0.00%)
After-Hours: 16:37
Lineage Cell Therapeutics EPS Diluted (Quarterly): -0.1301 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ocugen, Inc. | -0.066 |
| Belite Bio, Inc. | -0.6529 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.75M |
| Revenue (Quarterly) | 3.681M |
| Total Expenses (Quarterly) | 33.46M |
| Enterprise Value | 363.96M |
| Gross Profit Margin (Quarterly) | 95.03% |
| Profit Margin (Quarterly) | -808.3% |
| Earnings Yield | -17.60% |
| Normalized Earnings Yield | -8.593 |